Novartis Sells Shares Back to Roche for $20.7 Billion | BioSpace
$20.7B breakup: Novartis sells its stake in Roche | 2021-11-04 | BioWorld
Novartis could refuel M&A machine with $14 billion Roche stake sale | Reuters
Novartis willing to sell Roche stake without demanding premium - CEO | Reuters
Novartis considers future of $14bn Roche stake
No sale for Novartis' $14B Roche stake, but the revamp's not done | Fierce Pharma
Novartis agrees to sell back its stake in Roche for $20.7bn
Novartis to sell its stake in Roche to Roche for $20.7bn
Novartis sells its Roche stake to Roche for $20.7 bln
Novartis to Prepare the Sale of Its Roche Stake: Sonntagszeitung
Novartis to Sell Roche Stake for $20.7 Billion - WSJ
Novartis launches $15B share buyback after huge windfall from Roche stake sale—but M&A is still in the cards | Fierce Pharma
Novartis to sell stake back to Roche for $20.7 billion | Mint
Novartis India | Novartis AG to sell nearly one-third voting stake in Roche - Telegraph India
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
Novartis puts $14B Roche stake up for sale: Reports | Fierce Pharma
Novartis is selling its Roche stake to Roche for $20.7 bln - THE CEO PUBLICATION
Novartis/Roche: When a Separation Makes Sense for Everyone - WSJ
Novartis cuts uneasy 20-year ties to Roche with $20.7bn voting stake sale | Arab News
Novartis is cashing out of Roche for $21B, 20 years after mega-merger that never happened - MedCity News
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3L5H7O5F6RPD7LKCUDTF5LWOEU.jpg "Novartis cuts uneasy 20-year ties to Roche with $20.7 bln voting stake sale | Reuters")
Novartis cuts uneasy 20-year ties to Roche with $20.7 bln voting stake sale | Reuters
Novartis expects new drugs to boost sales
